Intervention Review

Immunosuppressive agents for myasthenia gravis

  1. Ian K Hart1,*,
  2. Sivakumar Sathasivam2,
  3. Tarek Sharshar3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 21 AUG 2007

DOI: 10.1002/14651858.CD005224.pub2

How to Cite

Hart IK, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005224. DOI: 10.1002/14651858.CD005224.pub2.

Author Information

  1. 1

    The Walton Centre for Neurology and Neurosurgery, University Division of Neuroscience, Liverpool, UK

  2. 2

    The Walton Centre for Neurology and Neurosurgery, Neurology Department, Liverpool, UK

  3. 3

    Hôpital Raymond Poincaré, Service de Réanimation Médicale, Garches, Ile de France, France

*Ian K Hart, University Division of Neuroscience, The Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool, L9 7LJ, UK. i.k.hart@liverpool.ac.uk. ian@kirkhart.freeserve.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Wolfgang Girisch, Christiane Willhelm, Sven Gottschling, Ludwig Gortner, Sascha Meyer, Role of Cochrane Reviews in Pediatric Neurology, Pediatric Neurology, 2012, 46, 2, 63

    CrossRef

  2. 2
    Maria F. Finnis, Sandeep Jayawant, Juvenile Myasthenia Gravis: A Paediatric Perspective, Autoimmune Diseases, 2011, 2011, 1

    CrossRef

  3. 3
    F. Chenevier, H. Gervais-Bernard, F. Bouhour, C. Vial, Miastenie e sindromi miasteniche, EMC - Neurologia, 2011, 11, 3, 1

    CrossRef

  4. 4
    Roxanna Khorzad, Megan Whelan, Allen Sisson, G. D. Shelton, Myasthenia gravis in dogs with an emphasis on treatment and critical care management, Journal of Veterinary Emergency and Critical Care, 2011, 21, 3
  5. 5
    I. Pénisson-Besnier, Traitement de la myasthénie auto-immune, Revue Neurologique, 2010, 166, 4, 400

    CrossRef

  6. 6
    Clinical Neurology, 2010,

    CrossRef

  7. 7
    R. Amaya Villar, J. Garnacho-Montero, M.D. Rincón Ferrari, Patología neuromuscular en cuidados intensivos, Medicina Intensiva, 2009, 33, 3, 123

    CrossRef

  8. 8
    Charlotte Vrinten, Stephanie S. Weinreich, Rob JPM Scholten, Jan JGM Verschuuren, 3,4-Diaminopyridine for myasthenia gravis, The Cochrane Library,
  9. 9
    Man Mohan Mehndiratta, Sanjay Pandey, Thierry Kuntzer, Acetylcholinesterase inhibitor treatment for myasthenia gravis, The Cochrane Library,
  10. 10
    Christiane Schneider-Gold, Philippe Gajdos, Klaus V Toyka, Reinhard R Hohlfeld, Corticosteroids for myasthenia gravis, The Cochrane Library,
  11. 11
    Charlotte Vrinten, Stephanie S Weinreich, Rob JPM Scholten, Jan JGM Verschuuren, Ephedrine for myasthenia gravis, The Cochrane Library,
  12. 12
    Michael Benatar, Ted Burns, Anthony V Swan, Serological, pharmacological and electrophysiological tests for the diagnosis of myasthenia gravis, The Cochrane Library,
  13. 13
    Gabriel Cea, Michael Benatar, Renato J Verdugo, Rodrigo A Salinas, Thymectomy for non-thymomatous myasthenia gravis, The Cochrane Library,
  14. 14
    Gabriel Cea, Michael Benatar, Renato J Verdugo, Rodrigo A Salinas, Thymectomy for non-thymomatous myasthenia gravis, The Cochrane Library,